What Is Primary Lateral Sclerosis?
Source: Genetic and Rare Diseases (GARD) Information Center
You can contact us here
Primary Lateral Sclerosis
PLS; Adult-onset PLS; Adult-onset primary lateral sclerosis
Primary lateral sclerosis (PLS) is a rare neuromuscular disease that affects the upper motor neurons of the arms, legs, and face. PLS is more common in men than in women, with a very gradual onset that generally occurs between ages 40 and 60.
Spinal Neuron
Image by Scientific Animations, Inc.
Difference in the physical exam findings seen between UMN vs LMN lesions.
Image by Rcchang16
Source: Genetic and Rare Diseases (GARD) Information Center
Spinal Neuron
Image by Scientific Animations, Inc.
Primary lateral sclerosis (PLS) affects only the upper motor neurons, causing the movements in the arms, legs, and face to be slow and difficult. The disorder often affects the legs first, followed by the torso, arms and hands, and, finally, the muscles used for swallowing, speaking, and chewing.
The legs and arms become stiff, clumsy, slow, and weak, making it difficult to walk or carry out tasks requiring fine hand coordination. Speech may become slowed and slurred. Individuals may have difficultly balancing, increasing the risk of falls. Affected individuals may also experience emotional changes and become easily startled.
Like ALS, PLS most often occurs in midlife. It is more common in men than in women. The cause of PLS is unknown.
PLS is sometimes considered a variant of ALS, but it progresses much more slowly than ALS and is not fatal. A significant proportion of those with PLS will develop lower motor neuron disease, changing the diagnosis to ALS. Because of this, most neurologists monitor an individual for at least 4 years before making a diagnosis of PLS.
Source: National Institute of Neurological Disorders and Stroke (NINDS)
Motor Neuron
Image by OpenStax College
Primary lateral sclerosis (PLS) is a rare neuromuscular disease with slowly progressive weakness in voluntary muscle movement. PLS belongs to a group of disorders known as motor neuron diseases. PLS affects the upper motor neurons (also called corticospinal neurons) in the arms, legs, and face. It occurs when nerve cells in the motor regions of the cerebral cortex (the thin layer of cells covering the brain which is responsible for most higher level mental functions) gradually degenerate, causing movements to be slow and effortful. The disorder often affects the legs first, followed by the body, trunk, arms and hands, and, finally the bulbar muscles (muscles that control speech, swallowing, and chewing). Symptoms include weakness, muscle stiffness and spasticity, clumsiness, slowing of movement, and problems with balance and speech. PLS is more common in men than in women, with a varied gradual onset that generally occurs between ages 40 and 60. PLS progresses gradually over a number of years, or even decades. Scientists do not believe PLS has a simple hereditary cause. The diagnosis of PLS requires extensive testing to exclude other diseases. When symptoms begin, PLS may be mistaken for amyotrophic lateral sclerosis (ALS) or spastic paraplegia. Most neurologists follow an affected individual's clinical course for at least 3 to 4 years before making a diagnosis of PLS..
Treatment for individuals with PLS is symptomatic. Muscle relaxants such as baclofen, tizanidine, and the benzodiazepines may reduce spasticity. Other drugs may relieve pain and antidepressants can help treat depression. Physical therapy, occupational therapy, and rehabilitation may prevent joint immobility and slow muscle weakness and atrophy. Assistive devices such as supports or braces, speech synthesizers, and wheelchairs ma help some people retain independence.. Speech therapy may be useful for those with involvement of the facial muscles.
PLS is not fatal. There is no cure and the progression of symptoms varies. Some people may retain the ability to walk without assistance, but others eventually require wheelchairs, canes, or other assistive devices.
Source: National Institute of Neurological Disorders and Stroke (NINDS)
Speech
Image by Manouk Abkarian/Wikimedia
Source: Genetic and Rare Diseases (GARD) Information Center
4 vials of human cerebrospinal fluid
Image by James Heilman, MD
Source: Genetic and Rare Diseases (GARD) Information Center
physical therapy
Image by Noun Project - https://thenounproject.com/icon/616 : Author undefined
Source: Genetic and Rare Diseases (GARD) Information Center
Get free access to in-depth articles and track your personal health.
Send this HealthJournal to your friends or across your social medias.